Operator of a drug development company. The company provides products that are designed to produce pharmacological treatment for prevention of thrombotic vascular disorders, including heart attack and stroke.
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Revitus‘s full profile, request access.
Request a free trialName | Title | Board Seat | Contact Info |
---|---|---|---|
Stephen Hanson Ph.D | Chief Executive Officer & Co-Founder | ||
Andras Gruber MD | Co-Founder |